BCYC Latest Press Releases

-- May 21, 2026 --

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting Business Wire 5:00 PM

-- April 30, 2026 --

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results Business Wire 7:00 AM

-- April 21, 2026 --

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting Business Wire 10:31 AM

-- April 20, 2026 --

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026 Business Wire 7:00 AM

-- March 18, 2026 --

Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026 Business Wire 7:00 AM

-- March 17, 2026 --

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results Business Wire 7:00 AM

-- February 3, 2026 --

Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline Business Wire 7:00 AM

-- January 12, 2026 --

Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software